Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Euro Surveill ; 29(32)2024 Aug.
Article in English | MEDLINE | ID: mdl-39119719

ABSTRACT

BackgroundA new respiratory virus surveillance platform, based on nationwide hospital laboratory data, was established in Israel during the COVID-19 pandemic.AimWe aimed to evaluate the performance of this platform with respect to the detection of influenza and respiratory syncytial virus (RSV) from week 36 in 2020 to week 15 in 2023, and how it fits with the World Health Organization (WHO) mosaic surveillance framework.MethodsData of respiratory samples from hospitalised patients sent for laboratory confirmation of influenza virus or RSV from 25 general hospital laboratories nationwide were collected. We analysed the weekly number and percentage of samples positive for influenza virus or RSV vis-à-vis SARS-CoV-2 activity and compared data from the new surveillance platform with existing surveillance platforms. Using data in the new surveillance platform, we analysed early stages of a 2021 out-of-season RSV outbreak and evaluated the capabilities of the new surveillance system with respect to objectives and domains of the WHO mosaic framework.ResultsThe new hospital-laboratory surveillance platform captured the activity of influenza virus and RSV, provided crucial data when outpatient sentinel surveillance was not operational and supported an out-of-season RSV outbreak investigation. The new surveillance platform fulfilled important objectives in all three domains of the mosaic framework and could serve for gathering additional information to fulfil more domain objectives.ConclusionThe new hospital laboratory surveillance platform provided essential data during the COVID-19 pandemic and beyond, fulfilled important domain objectives of the mosaic framework and could be adapted for the surveillance of other viruses.


Subject(s)
COVID-19 , Influenza, Human , Pandemics , Respiratory Syncytial Virus Infections , SARS-CoV-2 , World Health Organization , Humans , COVID-19/epidemiology , Israel/epidemiology , Respiratory Syncytial Virus Infections/epidemiology , Respiratory Syncytial Virus Infections/diagnosis , Influenza, Human/epidemiology , Influenza, Human/diagnosis , Sentinel Surveillance , Laboratories, Hospital/statistics & numerical data , Respiratory Syncytial Virus, Human/isolation & purification , Population Surveillance/methods
2.
Pediatr Nephrol ; 36(6): 1511-1514, 2021 06.
Article in English | MEDLINE | ID: mdl-33387020

ABSTRACT

BACKGROUND: Beta-2 microglobulin (ß2mG) is a low-molecular-weight protein that is almost exclusively eliminated through the kidneys. It is freely filtered in the glomeruli and almost completely reabsorbed and degraded in the proximal tubules. Normal urinary ß2mG levels are very low (between 0.04 and 0.22 mg/L). No reference values are known in infants and young children. METHODS: Urinary ß2mG levels were measured in 103 healthy term neonates during the first week of life by nephelometric technology. RESULTS: The average level of urinary ß2mG was 0.65 mg/L (95% confidence interval between 0 and 10.8 mg/L). There was a minor difference between male and female neonates but it did not reach statistical significance. There was no effect of the gestational week, birth weight, or weight loss in the first week of life, on urinary ß2mG levels. CONCLUSIONS: First-week urinary ß2mG levels in healthy term infants were higher than adult levels. Incomplete maturation of kidney tubules in neonates could be a possible explanation. These can now be used in clinical practice and further studies that assess the degree of proximal tubular function in health and disease. Graphical abstract.


Subject(s)
Urinalysis , beta 2-Microglobulin , Creatinine , Female , Humans , Infant, Newborn , Kidney , Kidney Glomerulus , Kidney Tubules , Male , Reference Values , beta 2-Microglobulin/urine
3.
Pediatr Nephrol ; 27(7): 1097-102, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22350370

ABSTRACT

BACKGROUND: Three patients with Dent's disease presented with complaints of impaired night vision or xerophthalmia and were found to have severely decreased serum retinol concentrations. Retinol, bound to its carrier retinol-binding protein (RBP), is filtered at the glomerulus and reabsorbed at the proximal tubule. We hypothesized that urinary loss of retinol-RBP complex is responsible for decreased serum retinol. OBJECTIVE AND METHODS: The study aim was to investigate vitamin A status and RBP in serum and urine of patients with genetically confirmed Dent's disease. RESULTS: Eight patients were studied, three boys had clinical vitamin A deficiency, three had asymptomatic deficiency, and two young men with Dent's disease and impaired renal function had normal retinol values. Serum RBP concentrations were low in patients with vitamin A deficiency and were correlated with vitamin A levels. Urinary RBP concentrations were increased in all patients (2,000-fold), regardless of vitamin A status. This was in contrast to patients with glomerular proteinuria who had only mildly increased urinary RBP with normal serum RBP and vitamin A, and patients with cystinosis with impaired renal function who had massive urinary RBP losses but without a decrease in serum RBP or vitamin A levels. Treatment with vitamin A supplements in patients with retinol deficiency resulted in rapid resolution of ocular symptoms and an increase in serum retinol concentrations. CONCLUSIONS: Vitamin A deficiency is common in patients with Dent's disease and preserved renal function. We therefore recommend screening these patients for retinol deficiency and treating them before visual symptoms develop.


Subject(s)
Dent Disease/complications , Dent Disease/metabolism , Retinol-Binding Proteins/urine , Vitamin A Deficiency/etiology , Vitamin A Deficiency/metabolism , Child , Child, Preschool , Chloride Channels/genetics , DNA Mutational Analysis , Dent Disease/physiopathology , Humans , Male , Mutation , Night Blindness/etiology , Vitamin A/therapeutic use , Vitamin A/urine , Vitamin A Deficiency/physiopathology , Vitamins/therapeutic use
4.
Kidney Blood Press Res ; 34(2): 116-24, 2011.
Article in English | MEDLINE | ID: mdl-21311195

ABSTRACT

INTRODUCTION: We tested the hypothesis that urinary and serum neutrophil gelatinase-associated lipocalins (NGAL) early after non-cardiac major surgery predict postoperative acute kidney injury (AKI), complications and mortality. METHODS: We studied 74 patients undergoing orthopedic, vascular and abdominal surgery lasting ≥2 h. NGAL was measured in preoperative, as well as 2- and 6-hour postoperative samples. The primary outcome was AKI. Secondary outcome was postoperative infection and death. RESULTS: 10 patients (13.5%) developed AKI, 19 (26%) reached secondary outcomes, of whom 5 (7%) died. Serum NGAL was significantly higher in patients with diabetes and chronic kidney disease (CKD). No significant correlation was detected between serum or urine NGAL and subsequent development of AKI. Urine NGAL at 6 h and serum NGAL at 2 and 6 h were strongly correlated with postoperative infection and death (p = 0.004, p = 0.013 and p = 0.001, respectively). CONCLUSIONS: Our data suggest that in the general surgical population, NGAL could serve as a potent early biomarker for postoperative infection, and that the presence of CKD and diabetes mellitus is associated with higher levels of NGAL and may influence its predictive value.


Subject(s)
Acute-Phase Proteins/analysis , Lipocalins/analysis , Postoperative Complications/diagnosis , Postoperative Complications/mortality , Predictive Value of Tests , Proto-Oncogene Proteins/analysis , Acute Kidney Injury/etiology , Acute-Phase Proteins/urine , Aged , Biomarkers/blood , Biomarkers/urine , Diabetes Mellitus , Female , Humans , Lipocalin-2 , Lipocalins/blood , Lipocalins/urine , Male , Middle Aged , Proto-Oncogene Proteins/blood , Proto-Oncogene Proteins/urine , Renal Insufficiency, Chronic , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL